N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide

C32H41NO4 — CID 11432089

IUPACN-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide
SMILESCOc1ccc2c(c1)CC[C@H]1[C@@H]3[C@H](CCCCCC(=O)NCc4ccc(O)cc4)CC(=O)[C@@]3(C)CC[C@H]21
InChIInChI=1S/C32H41NO4/c1-32-17-16-27-26-15-13-25(37-2)18-22(26)10-14-28(27)31(32)23(19-29(32)35)6-4-3-5-7-30(36)33-20-21-8-11-24(34)12-9-21/h8-9,11-13,15,18,23,27-28,31,34H,3-7,10,14,16-17,19-20H2,1-2H3,(H,33,36)/t23-,27-,28-,31+,32-/m1/s1
InChIKeyQCYZVGWFEFUFPX-TYVLPFHYSA-N
MW503.68 g/mol
LogP6.32
Rot. Bonds9

About N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide

N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide (PubChem CID 11432089) has the molecular formula C32H41NO4 and a molecular weight of 503.68 g/mol. Its IUPAC name is N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide.

Molecular Properties

Compound NameN-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide
PubChem CID11432089
Molecular FormulaC32H41NO4
Molecular Weight503.68 g/mol
Exact Mass503.30
IUPAC NameN-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide
SMILESCOc1ccc2c(c1)CC[C@H]1[C@@H]3[C@H](CCCCCC(=O)NCc4ccc(O)cc4)CC(=O)[C@@]3(C)CC[C@H]21
InChIInChI=1S/C32H41NO4/c1-32-17-16-27-26-15-13-25(37-2)18-22(26)10-14-28(27)31(32)23(19-29(32)35)6-4-3-5-7-30(36)33-20-21-8-11-24(34)12-9-21/h8-9,11-13,15,18,23,27-28,31,34H,3-7,10,14,16-17,19-20H2,1-2H3,(H,33,36)/t23-,27-,28-,31+,32-/m1/s1
InChIKeyQCYZVGWFEFUFPX-TYVLPFHYSA-N
XLogP6.32
TPSA75.63 Ų
H-Bond Donors2
H-Bond Acceptors4
Rotatable Bonds9
Heavy Atoms37
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500503.68
LogP ≤ 56.32
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide?
The IUPAC name of N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide (CID 11432089) is N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide.
What is the SMILES notation for N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide?
The canonical SMILES for N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide is COc1ccc2c(c1)CC[C@H]1[C@@H]3[C@H](CCCCCC(=O)NCc4ccc(O)cc4)CC(=O)[C@@]3(C)CC[C@H]21.
What is the InChIKey of N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide?
The InChIKey is QCYZVGWFEFUFPX-TYVLPFHYSA-N. The full InChI is InChI=1S/C32H41NO4/c1-32-17-16-27-26-15-13-25(37-2)18-22(26)10-14-28(27)31(32)23(19-29(32)35)6-4-3-5-7-30(36)33-20-21-8-11-24(34)12-9-21/h8-9,11-13,15,18,23,27-28,31,34H,3-7,10,14,16-17,19-20H2,1-2H3,(H,33,36)/t23-,27-,28-,31+,32-/m1/s1.
What are the key properties of N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide?
N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide has a molecular weight of 503.68 g/mol, XLogP of 6.32, 9 rotatable bonds, 2 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(4-hydroxyphenyl)methyl]-6-[(8R,9S,13S,14S,15R)-3-methoxy-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-15-yl]hexanamide is sourced from PubChem (CID 11432089), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).